Dr. Afshin Beheshti is a systems biologist whose research spans spaceflight health, radiation biology, cancer, cardiovascular systems, and infectious disease, with a unifying focus on the interplay between microRNAs and mitochondrial function. His work integrates AI and machine learning with multi omics analyses and experimental validation to identify biomarkers and therapeutic targets. His research, funded by NASA, NIH, and DoD, and published in journals including Nature, Cell, and Science Translational Medicine, has uncovered miRNA and mitochondrial signatures underlying astronaut health risks, long COVID pathophysiology, and cancer progression. He serves as President of the COVID-19 International Research Team (COV-IRT), a global consortium of over 200 scientists, and co-founded TesaBio AI, an AI driven drug repurposing platform. He previously served as a PI at NASA Ames and helped develop NASA GeneLab, where he continues to lead the Multi-Omics Analysis Working Group.
EDUCATION AND TRAINING
Ph.D., Physics, Florida State University, 2002
M.S., Physics, Florida State University, 2000
B.S., Physics, University of Minnesota, 1997
Postdoctoral Research, The Forsyth Institute (2003 to 2006) and Center of Cancer Systems Biology, Tufts University School of Medicine (2006 to 2008)
SELECTED APPOINTMENTS
Professor of Surgery, University of Pittsburgh, 2024 to present
Professor of Computational and Systems Biology, University of Pittsburgh, 2024 to present
Professor of Bioengineering, University of Pittsburgh, 2026 to present
Director, Center for Space Biomedicine, University of Pittsburgh, 2024 to present
Associate Director, McGowan Institute for Regenerative Medicine, University of Pittsburgh, 2024 to present
Visiting Researcher, Stanley Center for Psychiatric Research, Broad Institute of MIT and Harvard, 2019 to present
President, COVID-19 International Research Team (COV-IRT), 2020 to present
Research Scientist, NASA Ames Research Center, 2017 to 2024
SELECTED HONORS AND AWARDS
International Space Station Research and Development Award for Compelling Results in Biology, 2021
NASA Outstanding Service Award, NASA Ames Safety Award Program II, 2022
NASA Exceptional Scientific Achievement Medal, 2019
SCHOLARLY IMPACT AND SELECTED PUBLICATIONS
h-index: 43 | i10-index: 95 | Citations: over 6,000 | 120+ peer reviewed articles
Chia SB, ... Beheshti A, ... DeGregori J. Respiratory viral infections awaken metastatic breast cancer cells in lungs. Nature, 2025.
Winer DA, ... Beheshti A, ... Crucian BE. Astroimmunology: the effects of spaceflight and its associated stressors on the immune system. Nature Reviews Immunology, 2026.
Mason CE, ... Beheshti A. A second space age spanning omics, platforms and medicine across orbits. Nature, 2024.
Overbey EG, ... Beheshti A, ... Mason CE. The Space Omics and Medical Atlas (SOMA) and international astronaut biobank. Nature, 2024.
Jones CW, ... Beheshti A, ... Mason CE. Molecular and physiological changes in the SpaceX Inspiration4 civilian crew. Nature, 2024.
Galeano D, ... Beheshti A. sChemNET: a deep learning framework for predicting small molecules targeting microRNA function. Nature Communications, 2024.
Guarnieri JW, ... Beheshti A*, Wallace DC*. Core mitochondrial genes are down-regulated during SARS-CoV-2 infection of rodent and human hosts. Science Translational Medicine, 2023.
Topper MJ, ... Beheshti A*, Wallace DC*, Baylin SB*. Lethal COVID-19 associates with RAAS-induced inflammation for multiple organ damage including mediastinal lymph nodes. Proceedings of the National Academy of Sciences, 2024.
da Silveira WA, ... Beheshti A. Comprehensive multi-omics analysis reveals mitochondrial stress as a central biological hub for spaceflight impact. Cell, 2020.
Afshinnekoo E, ... Beheshti A. Fundamental biological features of spaceflight: advancing the field to enable deep-space exploration. Cell, 2020.
SELECTED RECENT INVITED TALKS
Mitochondria Key Driver in Health Risks Associated with Space Radiation. American Society for Radiation Oncology (ASTRO) 67th Annual Meeting, San Francisco, CA, September 2025 (invited talk, space radiation session).
Space Medicine and the Future of Human Exploration. American College of Veterinary Pathologists Annual Meeting, New Orleans, LA, October 2025 (invited plenary session).
Comprehensive Multiomics Analysis Reveals Mitochondrial Stress as the Epicenter of Spaceflight Impact. Multiomics in Precision Medicine, Philadelphia, PA, June 2025.
Invited participant, Sci Foo 2025, Google, Palo Alto, CA, July 2025.
Mitochondrial Stress as the Epicenter of Spaceflight Impact and microRNAs as Promising Countermeasures. 9th Annual Dr. Radha Maheshwari Memorial Lecture, Uniformed Services University, Washington, DC, March 2025.
Mitochondrial Stress as a Central Biological Hub for Spaceflight Impact. 14th World Congress on Targeting Mitochondria, Berlin, Germany, October 2023.
Panel Session on Space Biomedicine. Keystone Space Collaborative Annual Conference, Pittsburgh, PA, October 2024.
Otsuka Kaempferol Product Launch, invited speaker. Otsuka Pharmaceutical, Tokyo, Japan, February 2026.
LEADERSHIP AND PROFESSIONAL SERVICE
Lead, NASA GeneLab Multi-Omics Analysis Working Group
Co-founder, TesaBio AI, an AI driven drug repurposing platform
Associate Editor, Integrative Biology, 2025 to 2026
Guest Associate Editor, Frontiers in Astronomy and Space Sciences: Astrobiology, 2023
Special Issue Editor, Cell Press, The Biology of Spaceflight, 2020; and Deep Space and Countermeasures, in progress
Special Issue Editor, Nature Portfolio, Space Omics and Medical Atlas (SOMA) Across Orbits, 2024